Literature DB >> 35180463

Schizophrenia after remission of anti-NMDA receptor encephalitis.

Kasumi Yasuda1, Shinya Uenishi2, Hiroshi Sakamoto3, Kohei Hori4, Jinsoo Koh4, Shun Takahashi5.   

Abstract

N-methyl-D-aspartate receptor (NMDAR) dysfunction is an attractive hypothesis regarding the etiology of schizophrenia. We present the unprecedented case of a woman diagnosed with schizophrenia without anti-NMDAR antibodies after history of NMDAR encephalitis. A first episode of psychosis was antibody-positive and was improved with steroid and immunoglobulin treatment. Second and third episodes were antibody-negative, each about three months postpartum (different pregnancies) and were improved with antipsychotics. Without NMDAR encephalitis-related findings, we diagnosed schizophrenia. After anti-NMDAR encephalitis, NMDAR dysfunction may decrease the threshold for the onset of psychosis. This case provides insight into NMDAR dysfunction on etiology of schizophrenia.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  NMDA receptor; NMDAR encephalitis; Schizophrenia

Mesh:

Substances:

Year:  2022        PMID: 35180463     DOI: 10.1016/j.ajp.2022.103027

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  1 in total

Review 1.  NMDAR autoantibodies in psychiatric disease - An immunopsychiatric continuum and potential predisposition for disease pathogenesis.

Authors:  Niels Hansen
Journal:  J Transl Autoimmun       Date:  2022-09-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.